Organovo collabs with UOV in developing bioprinting for VML

Image: From "The Bioprinting Process" video on Organovo website - www.organovo.com

Organovo Holdings, Inc., a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting technology, has announced a collaboration with the University of Virginia to develop 3D bioprinted tissues for volumetric muscle loss (“VML”) injury. The research will take place in the laboratory of George J. Christ, Ph.D., professor of biomedical engineering and orthopaedic surgery at UVA.

The Christ lab has conducted extensive studies in regeneration and advancement of biomaterials. It is part of the Advanced Regenerative Manufacturing Institute, which brings together a consortium including UVA and nearly 100 other partners from industry, government, academia and the non-profit sector. The placement of an Organovo printer in this consortium will provide the institute an important technology to aide in achieving their goal of manufacturing human tissues and organs for therapeutic use.

The UVA collaboration is one of multiple 3D bioprinter placements that Organovo has with the world’s leading government and academic research institutions.